Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.

Jent, Philipp; Trippel, Mafalda; Frey, Manuel; Pöllinger, Alexander; Berezowska, Sabina; Langer, Rupert; Furrer, Hansjakob; Béguelin, Charles Antoine (2018). Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient. Open Forum Infectious Diseases, 5(11), ofy244. Oxford University Press 10.1093/ofid/ofy244

[img]
Preview
Text
ofy244.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (332kB) | Preview

We report the case of a young patient treated with rituximab-containing chemotherapy who was infected with measles despite previous vaccination. Treatment with vitamin A, ribavirin, and immunoglobulins was started; nevertheless he developed severe pneumonitis and deceased. Broad vaccination coverage is crucial in protecting vulnerable subjects.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology
04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic of Intensive Care

UniBE Contributor:

Jent, Philipp; Trippel, Mafalda; Frey, Manuel; Pöllinger, Alexander; Berezowska, Sabina Anna; Langer, Rupert; Furrer, Hansjakob and Béguelin, Charles Antoine

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

2328-8957

Publisher:

Oxford University Press

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

10 Jan 2019 10:22

Last Modified:

13 Jan 2019 02:37

Publisher DOI:

10.1093/ofid/ofy244

PubMed ID:

30397623

Uncontrolled Keywords:

immunocompromised measles rituximab vaccination

BORIS DOI:

10.7892/boris.121127

URI:

https://boris.unibe.ch/id/eprint/121127

Actions (login required)

Edit item Edit item
Provide Feedback